Login/Register 
United States ($) USD
Austria (€) EUR
Belgium (€) EUR
Finland (€) EUR
France (€) EUR
Germany (€) EUR
Ireland (€) EUR
Japan (¥) JPY
Luxembourg (€) EUR
Netherlands (€) EUR
Switzerland (CHF) CHF
United Kingdom (£) GBP
- Regulatory Status
- RUO
- Other Names
- Colony Stimulating Factor 3 Receptor (CSF3R), Granulocyte Colony-Stimulating Factor Receptor (GCSFR), CD114, CD114 Antigen, G-CSF-R, SCN7
- Ave. Rating
- Submit a Review
- Product Citations
- publications
-
Human G-CSFR inhibits the proliferation of M-NFS-60 mouse myeloid cells induced by 0.4 ng/ml of human G-CSF. -
Stability testing for human G-CSFR. Human G-CSFR was aliquoted in PBS at 0.2 mg/ml and was treated as followed: one aliquot was kept at 4°C (control) and another was freeze-thawed four times (4 x freeze-thaws). After this procedure, the samples were tested for their ability to inhibit the proliferation of M-NFS-60 mouse myeloid cells induced by 0.4 ng/ml of human G-CSF.
| Cat # | Size | Price | Quantity Check Availability | Save | ||
|---|---|---|---|---|---|---|
| 769902 | 10 µg | $218 | ||||
| 769904 | 25 µg | $440 | ||||
Human G-CSF receptor (CSF3R) was initially isolated from the cDNA libraries of human U937 leukemia cells. The human G-CSF receptor is a type I cytokine receptor, possesses 836 amino acids, and has a clear homology (62.5%) with its murine counterpart. G-CSFR contains a conserved cytokine receptor homologous (CRH) domain, an Ig-like domain and three fibronectin type III-like domains in the extracellular region; a transmembrane region; and an intracellular region lacking intrinsic catalytic activity. Human G-CSF soluble receptor has been identified this form has a deletion of the transmembrane domain. The complex G-CSF/G-CSFR has a 2:2 ligand:receptor stoichiometry. G-CSFR stimulates signals transduction proteins that induce granulocytic proliferation and differentiation such as the STAT 1, 3 and 5 transcription factors, the Ras/Mek/Erk1/2 pathway, the Src-related kinases Lyn and Hck, the serine/threonine kinase Akt, and the Syk tyrosine kinas. Also, G-CSFR is associated to pathways that negatively regulate granulopoiesis, including those mediated by the SHP-1 tyrosine phosphatase and the suppressor of cytokine signaling 3 (SOCS3) protein. Different mutations in the gene encoding the G-CSFR have been described with clinical consequences related to the myeloid lineage, including severe congenital neutropenia (SCN), myelodysplastic syndrome (MDS), acute myeloid leukemia (AML), and chronic neutrophilic leukemia (CNL).
Product DetailsProduct Details
- Source
- Human G-CSFR, amino acids (Glu25-His627) (Accession # Q99062) was expressed in CHO cells. The carboxy terminus contains TGSR+hlgG-Fc+6His tag.
- Molecular Mass
- The 847 amino acid recombinant protein has a predicted molecular mass of approximately 94.7kD. The DTT-reduced and non-reduced protein migrate at approximately 115 kD and >200 kD respectively by SDS-PAGE. The predicted N-terminal amino acid is Glu.
- Purity
- >95% by SDS-PAGE gel as determined by Coomassie stained SDS-PAGE.
- Formulation
- 0.22 µm filtered protein solution is in PBS pH7.2.
- Endotoxin Level
- Less than 0.1 EU per µg (0.01 ng/µg) cytokine as determined by the LAL method.
- Concentration
- 10 and 25 µg sizes are bottled at 200 µg/mL.
- Storage & Handling
- Unopened vial can be stored between 2°C and 8°C for up to 2 weeks, at -20°C for up to six months, or at -70°C or colder until the expiration date. For maximum results, quick spin vial prior to opening. The protein can be aliquoted and stored at -20°C or colder. Stock solutions can also be prepared at 50 - 100 µg/mL in appropriate sterile buffer, carrier protein such as 0.2 - 1% BSA or HSA can be added when preparing the stock solution. Aliquots can be stored between 2°C and 8°C for up to one week and stored at -20°C or colder for up to 3 months. Avoid repeated freeze/thaw cycles.
- Activity
- Human G-CSFR inhibits the proliferation of M-NFS-60 mouse myeloid cells measured using Deep Blue Cell Viability™ Kit (Cat. No. 424701) and induced by 0.4 ng/ml of human G-CSF (Cat. No. 578602). The ED50 = 2 - 10 ng/ml.
- Application
-
Bioassay
- Application Notes
-
BioLegend carrier-free recombinant proteins provided in liquid format are shipped on blue-ice. Our comparison testing data indicates that when handled and stored as recommended, the liquid format has equal or better stability and shelf-life compared to commercially available lyophilized proteins after reconstitution. Our liquid proteins are verified in-house to maintain activity after shipping on blue ice and are backed by our 100% satisfaction guarantee. If you have any concerns, contact us at tech@biolegend.com.
Antigen Details
- Structure
- Cytokine receptor
- Distribution
-
Neutrophils, hematopoietic progenitor cells, placenta neurons, adult neural stem cells, endothelial cells, and cardiomyocytes.
- Function
- Controls production, differentiation, and function of granulocytes. Integrin α9β1 augments receptor signaling and granulopoiesis in vivo.
- Interaction
- G-CSFR interacts with integrin α9β1.
- Ligand/Receptor
- G-CSF
- Bioactivity
- G-CSFR inhibits the proliferation of M-NFS-60 cells.
- Cell Type
- Hematopoietic stem and progenitors, Embryonic Stem Cells
- Biology Area
- Stem Cells
- Molecular Family
- Soluble Receptors, Cytokine/Chemokine Receptors
- Antigen References
-
- Fukunaga R, et al. 1990. PNAS USA. 87:8702.
- Larsen A, et al. 1990. J Exp Med. 172:1559-70.
- Tamada T, et al. 2006. PNAS USA. 103:3135.
- Chen C, et al. 2006. Immunity. 25:895.
- Panopoulos AD, Watowich SS. 2008. Cytokine. 42:277.
- Liongue C, Ward AC. 2014. Front Oncol. 4:93.
- Gene ID
- 1441 View all products for this Gene ID
- UniProt
- View information about G-CSF on UniProt.org
Related FAQs
- Why choose BioLegend recombinant proteins?
-
• Each lot of product is quality-tested for bioactivity as indicated on the data sheet.
• Greater than 95% Purity or higher, tested on every lot of product.
• 100% Satisfaction Guarantee for quality performance, stability, and consistency.
• Ready-to-use liquid format saves time and reduces challenges associated with reconstitution.
• Bulk and customization available. Contact us.
• Learn more about our Recombinant Proteins. - How does the activity of your recombinant proteins compare to competitors?
-
We quality control each and every lot of recombinant protein. Not only do we check its bioactivity, but we also compare it against other commercially available recombinant proteins. We make sure each recombinant protein’s activity is at least as good as or better than the competition’s. In order to provide you with the best possible product, we ensure that our testing process is rigorous and thorough. If you’re curious and eager to make the switch to BioLegend recombinants, contact your sales representative today!
- What is the specific activity or ED50 of my recombinant protein?
-
The specific activity range of the protein is indicated on the product datasheets. Because the exact activity values on a per unit basis can largely fluctuate depending on a number of factors, including the nature of the assay, cell density, age of cells/passage number, culture media used, and end user technique, the specific activity is best defined as a range and we guarantee the specific activity of all our lots will be within the range indicated on the datasheet. Please note this only applies to recombinants labeled for use in bioassays. ELISA standard recombinant proteins are not recommended for bioassay usage as they are not tested for these applications.
- Have your recombinants been tested for stability?
-
Our testing shows that the recombinant proteins are able to withstand room temperature for a week without losing activity. In addition the recombinant proteins were also found to withstand four cycles of freeze and thaw without losing activity.
- Does specific activity of a recombinant protein vary between lots?
-
Specific activity will vary for each lot and for the type of experiment that is done to validate it, but all passed lots will have activity within the established ED50 range for the product and we guarantee that our products will have lot-to-lot consistency. Please conduct an experiment-specific validation to find the optimal ED50 for your system.
- How do you convert activity as an ED50 in ng/ml to a specific activity in Units/mg?
-
Use formula Specific activity (Units/mg) = 10^6/ ED50 (ng/mL)
Follow Us